MedTrace Logo

Myomo e100 NeuroRobotic System Home Safety Study

NCT00820638 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2009-01-12

No results posted yet for this study

Summary

Up to 25 subjects will use the Myomoe100 in the home setting under the distant supervision of an occupational therapist. We will look to see if they can perform functional activities safely without adverse events.

Conditions

Interventions

DEVICE

myomo e100

use of the myomo e100 in home

Sponsors & Collaborators

  • Myomo

    lead INDUSTRY

Principal Investigators

  • Richard Hughes, MSPT · Myomo

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-11-30
Primary Completion
2009-06-30
Completion
2009-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00820638 on ClinicalTrials.gov